156 related articles for article (PubMed ID: 12575315)
21. [Transitional cell carcinoma of the ovary: one kind of uncommon type of ovarian epithelial carcinoma].
Wu M; Shen K; Lang J; Huang R; Huang H; Pan L
Zhonghua Fu Chan Ke Za Zhi; 2002 Dec; 37(12):733-5. PubMed ID: 12622917
[TBL] [Abstract][Full Text] [Related]
22. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
Comin CE; Saieva C; Messerini L
Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
[TBL] [Abstract][Full Text] [Related]
23. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
24. [Primary peritoneal carcinoma: a report of two cases and a review of the literature].
Popovska S; Veselinova T; Gorchev G; Tomov S; Elenchev L
Akush Ginekol (Sofiia); 2005; 44(1):8-10. PubMed ID: 15853004
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological characteristics of mucinous adenocarcinoma of the ovary.
Shimada M; Kigawa J; Ohishi Y; Yasuda M; Suzuki M; Hiura M; Nishimura R; Tabata T; Sugiyama T; Kaku T
Gynecol Oncol; 2009 Jun; 113(3):331-4. PubMed ID: 19275957
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.
Schmeler KM; Sun CC; Bodurka DC; Deavers MT; Malpica A; Coleman RL; Ramirez PT; Gershenson DM
Gynecol Oncol; 2008 Mar; 108(3):510-4. PubMed ID: 18155273
[TBL] [Abstract][Full Text] [Related]
27. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.
Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104
[TBL] [Abstract][Full Text] [Related]
28. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of prognostic factors for stage III ovarian epithelial carcinoma].
Wu M; Shen K; Lang JH; Huang RL; Huang HF; Pan LY
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1406-9. PubMed ID: 16029654
[TBL] [Abstract][Full Text] [Related]
30. Cerebellar metastasis from papillary serous adenocarcinoma of the ovary mimicking Ménière's disease. A case report.
Chang TC; Jain S; Ng KK; Hsueh S; Tsai CS; Chen HL; Chang CN
J Reprod Med; 2001 Mar; 46(3):267-9. PubMed ID: 11304872
[TBL] [Abstract][Full Text] [Related]
31. The mistaken diagnosis of carcinoma of the ovary.
McGowan L; Norris HJ
Surg Gynecol Obstet; 1991 Sep; 173(3):211-5. PubMed ID: 1925882
[TBL] [Abstract][Full Text] [Related]
32. Extraovarian primary peritoneal papillary serous carcinoma.
Bhuyan P; Mahapatra S; Mahapatra S; Sethy S; Parida P; Satpathy S
Arch Gynecol Obstet; 2010 Mar; 281(3):561-4. PubMed ID: 19693524
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
[TBL] [Abstract][Full Text] [Related]
34. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
[TBL] [Abstract][Full Text] [Related]
35. [Primary peritoneal malignant tumor: clinical analysis of 28 cases].
Wu Y; Li WF
Ai Zheng; 2003 Nov; 22(11):1228-31. PubMed ID: 14613659
[TBL] [Abstract][Full Text] [Related]
36. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
[TBL] [Abstract][Full Text] [Related]
37. Serous psammocarcinoma of the ovary and peritoneum: two case reports and review of the literature.
Alanbay I; Dede M; Ustün Y; Karaşahin E; Deveci S; Günhan O; Yenen MC
Arch Gynecol Obstet; 2009 Jun; 279(6):931-6. PubMed ID: 18982336
[TBL] [Abstract][Full Text] [Related]
38. [Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas].
Pete I; Szánthó A; Mayer A; Thurzó L; Pulay T
Orv Hetil; 2003 May; 144(19):919-24. PubMed ID: 12809068
[TBL] [Abstract][Full Text] [Related]
39. Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary.
Gershenson DM; Sun CC; Lu KH; Coleman RL; Sood AK; Malpica A; Deavers MT; Silva EG; Bodurka DC
Obstet Gynecol; 2006 Aug; 108(2):361-8. PubMed ID: 16880307
[TBL] [Abstract][Full Text] [Related]
40. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
